Meet Global Liver Institute at TLMdX 2020

GLI-news-banner.png

Global Liver Institute (GLI) is dedicated to strengthening the alliance of patients, clinicians, and researcher communities to evolve the field of liver health. Join GLI at TLMdX to learn about our role in implementing the AASLD patient engagement strategy and GLI’s past, present and future advocacy and goals.


Join us for a session 

Meet and Greet: Patient Advisory Committee Members and Your Hepatology Community

Friday, November 13, at 1:15pm ET
Donna Cryer, JD, President & CEO, Global Liver Institute (Committee Member)
Join an interactive session to welcome and introduce the inaugural Patient Advisory Committee Members. Learn how to nominate for upcoming community member opportunities on the Committee and with AASLD.

Donna Cryer, JD, President and CEO, Global Liver Institute

Donna Cryer, JD, President and CEO, Global Liver Institute

Advocating for Liver Disease: Experiences From the Field

Saturday, November 14th at 12:15pm ET
Andrew Scott, Director of Policy at Global Liver Institute (Speaker)
Learn best practices in liver health advocacy and hear about opportunities to participate in liver health advocacy with Congress, FDA and CMS. This session will include a live Q&A.

Andrew Scott, Director of Policy, Global Liver Institute

Andrew Scott, Director of Policy, Global Liver Institute

Interactive Patient-Focused Abstract Tour: Public Health/Public Equity/Health Care Delivery 

Saturday, November 14th at 3:30 pm ET
Donna Cryer, JD, President & CEO, Global Liver Institute (Moderator/Guide) 
Experience brief curated presentations of key public health/health equity/healthcare delivery posters presented at TLMdX.


AASLD Annual Patients Forum

Sunday, November 15th at 12:15pm ET  
Donna Cryer, JD, President & CEO, Global Liver Institute (Co-Moderator)
AASLD leadership including President Jorge Bezerra, MD and Secretary Meena Bansal, MD welcome patient advocacy organization leaders and discuss patient engagement achievements and future areas for collaboration.



Navigating AASLD

Patient / Advocate TLMdX Schedule

Join the dedicated Patients & Advocates discussion board so you can be kept updated in real-time, be in the know about sessions taking place, and interact with fellow attendees. 


Listen to NASH-specific Meeting Analysis

Surfing The NASH Tsunami Podcast
The World's Leading Podcast for NASH and Fatty Liver Disease

Subscribe and listen online or on your favorite podcast app



Donna Cryer 3 2015.jpg

“At GLI, our role in the liver community is to push and challenge the status quo. We have worked to develop an advocacy agenda that builds visibility for all people impacted by liver disease, and presses for policy makers, regulators, and world leaders to take liver health seriously.”

Donna Cryer, JD, President & CEO, Global Liver Institute

Press ReleasesDonna Cryer